Synthesis 2015; 47(20): 3212-3220
DOI: 10.1055/s-0034-1380453
paper
© Georg Thieme Verlag Stuttgart · New York

Aryne-Mediated Arylation of the 3-Benzazepine Scaffold: One-Pot Synthesis of 1-Aryl-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepines

Kamal Nain Singh*
Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India   Email: kns@pu.ac.in
,
Paramjit Singh
Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India   Email: kns@pu.ac.in
,
Esha Sharma
Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India   Email: kns@pu.ac.in
,
Manjot Kaur
Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India   Email: kns@pu.ac.in
,
Yadwinder Singh Deol
Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India   Email: kns@pu.ac.in
› Author Affiliations
Further Information

Publication History

Received: 10 February 2015

Accepted after revision: 05 May 2015

Publication Date:
09 July 2015 (online)


Abstract

The coupling of β-amino carbanions derived from 3-benz­aze­pines with in situ generated arynes has been demonstrated as a convenient route for the direct synthesis of a variety of 1-aryl-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepines, including the biologically active drug molecule SCH 12679.

Supporting Information

 
  • References

    • 1a Mondeshka D, Angelova I, Ivanov CB, Ivanova NS. Arch. Pharm. (Weinheim, Ger.) 1990; 323: 829
    • 1b Yu Y, Wang J.-R, Sun P.-H, Guo Y, Zhang Z.-J, Jin G.-Z, Zhen X. J. Neurochem. 2008; 104: 946
    • 1c Wünsh B, Nerdinger S, Baushke G, Hofner G. Arch. Pharm. Med. Chem. 1997; 330: 211
    • 1d Kruk ZL, Pycock CJ. Neurotransmitters and Drugs . 3rd ed. Chapman & Hall; London: 1991
    • 1e Danysz W, Parsons CG, Bresink I, Quack G. Drug News Perspect. 1995; 8: 261
    • 1f Weinstock J, Ladd DL, Wilson JW, Brush CK, Hahn RA. J. Med. Chem. 1986; 29: 2315
    • 1g Berger JG, Grove C, Chang WK, Gold EH. US 4996202, 1991
    • 2a Chumpradit S, Kung HF, Billings J, Pan S. J. Med. Chem. 1989; 32: 1431
    • 2b Hyttel J. Eur. J. Pharmacol. 1983; 91: 153
    • 2c Iorio LC, Barnett A, Leitz FH, Houser VP. J. Pharmacol. Exp. Ther. 1983; 226: 462
    • 2d Friedman AM, Dejesus OT, Woolverton WL, Moffaert GV, Goldberg LI, Prasad A. Eur. J. Pharmacol. 1985; 108: 327
    • 2e Sidhu A, Kebabian JW. Eur. J. Pharmacol. 1985; 113: 437
    • 2f Boyson SJ, McGonigle P, Molinoff PB. J. Neurosci. 1986; 6: 3177
    • 2g Yamamoto T, Kebabian JW. Brain Res. 1987; 407: 398
    • 2h Kung HF, Billings J, Guo Y.-Z, Blau M, Ackerhalt RA. Int. J. Nucl. Med. Biol. 1988; 15: 187
    • 3a Katz RJ, Thomas E. Psychopharmacology 1976; 48: 79
    • 3b Stanley M, Wilk S. Eur. J. Pharmacol. 1977; 44: 293
    • 3c Koe BK. J. Pharmacol. Exp. Ther. 1976; 199: 649
    • 3d Costall B, Naylor RJ. Eur. J. Pharmacol. 1975; 33: 301
    • 4a Neumeyer JL, Baindur N, Yuan J, Booth G, Seeman P. J. Med. Chem. 1990; 33: 521
    • 4b Baindur N, Neumeyer JL, Niznik HB, Jarvie KR, Seeman P, Garlick RK. J. Med. Chem. 1988; 31: 2069
  • 5 Coote SJ, Davies SG, Middlemiss D, Naylor A. Tetrahedron Lett. 1989; 30: 3581
    • 6a Ruchirawat S, McMohan RM, Thornber CW. J. Chem. Soc., Perkin Trans. 1 1982; 2163
    • 6b Kametani T, Hirata S, Shibuya S, Fukumoto K. J. Chem. Soc. C 1971; 1927
  • 7 Crecente-Campo J, Vázquez-Tato MP, Seijas JA. Tetrahedron 2009; 65: 2655
    • 8a Kessar SV, Singh P, Vohra R, Kaur NP, Singh KN. J. Chem. Soc., Chem. Commun. 1991; 568
    • 8b Kessar SV, Singh P. Chem. Rev. 1997; 97: 721
    • 9a Kessar SV, Singh P, Singh KN, Venugopalan P, Kaur A, Mahendru M, Kapoor R. Tetrahedron Lett. 2005; 46: 6753
    • 9b Ito Y, Nakatsuka M, Saegusa T. J. Am. Chem. Soc. 1982; 104: 7609
    • 9c Blagg J, Coote SJ, Davies SG. J. Chem. Soc., Perkin Trans. 1 1987; 689
  • 10 Lata S. Ph.D. Thesis. Panjab University; India: 2008
  • 11 Singh KN, Singh P, Sharma E, Deol YS. Synthesis 2014; 46: 1739
  • 12 Singh KN, Singh P, Singh P, Deol YS. Org. Lett. 2012; 14: 2202
  • 13 Treatment of aryl chlorides or fluorides with alkyllithium at low temperature was used for aryne generation as these conditions are compatible with generation and reactions of amino carbanions, see refs. 11 and 12.
  • 14 Halford JO, Weissmann B. J. Org. Chem. 1952; 17: 1646
  • 15 All new products were characterized by 1H and 13C NMR, IR spectroscopy, HRMS, and CHN analysis.
    • 16a Hofmann RW. Dehydrobenzene and Cycloalkynes . Academic Press; New York: 1967: 134-150
    • 16b Also see refs. 11 and 12.
    • 17a This experiment on a larger scale was carried out on the suggestion of a reviewer.
    • 17b The formation of similar side products in the reaction of lithiated 2-methyl-1,2,3,4-tetrahydroisoquinoline moiety with benzyne was noted in our earlier publication11 as well.
  • 18 Fisch JJ. Res. Chem. Intermed. 1996; 22: 145
  • 19 Beaven GH, Hassan M, Johnson EA, Klassen NV. J. Chem. Soc. 1961; 2749
    • 20a Logullo FM, Seitz AM, Friedman L. Org. Synth. 1968; 48: 12
    • 20b Heaney H, Millar IT. Org. Synth. 1960; 40: 105
  • 21 Furniss BS. Vogel’s Textbook of Practical Organic Chemistry . 4th ed. ELBS/Longman; London: 1978: 266
  • 22 Fagan PJ, Nugent WA. Org. Synth. 1992; 70: 272
    • 23a Bearss DJ, Grand CL, Liu X.-H, Vankayalapati H. WO 2008055233, 2008 ; Chem. Abstr. 2008, 148, 538306.
    • 23b Yu Q, Jin Y, Zhou Z.-Y, Tian W, Long Y.-Q. Bioorg. Med. Chem. Lett. 2006; 16: 5864
    • 23c Roy SC, Rana KK, Guin C, Banerjee B. Synlett 2003; 221
  • 24 Furniss BS. Vogel’s Textbook of Practical Organic Chemistry . 4th ed. ELBS/Longman; London: 1978: 755